352 related articles for article (PubMed ID: 26489389)
1. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
[TBL] [Abstract][Full Text] [Related]
3. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study.
Hird A; Zhang L; Holt T; Fairchild A; DeAngelis C; Loblaw A; Wong R; Barnes E; Tsao M; Danjoux C; Chow E
Clin Oncol (R Coll Radiol); 2009 May; 21(4):329-35. PubMed ID: 19232483
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study.
van der Linden YM; Westhoff PG; Stellato RK; van Baardwijk A; de Vries K; Ong F; Wiggenraad R; Bakri B; Wester G; de Pree I; van Veelen L; Budiharto T; Schippers M; Reyners AKL; de Graeff A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):546-553. PubMed ID: 32446951
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S185-S194. PubMed ID: 29156903
[TBL] [Abstract][Full Text] [Related]
7. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
Am J Hosp Palliat Care; 2018 Apr; 35(4):718-723. PubMed ID: 28950727
[TBL] [Abstract][Full Text] [Related]
8. Should dexamethasone be standard in the prophylaxis of pain flare after palliative radiotherapy for bone metastases?-a debate.
Niglas M; Raman S; Rodin D; Detsky J; DeAngelis C; Soliman H; Chow E; Tsao MN
Ann Palliat Med; 2018 Apr; 7(2):279-283. PubMed ID: 28595438
[TBL] [Abstract][Full Text] [Related]
9. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.
Chow E; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Brundage MD; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Meyer RM; Chen BE; Wong RK
Lancet Oncol; 2014 Feb; 15(2):164-71. PubMed ID: 24369114
[TBL] [Abstract][Full Text] [Related]
10. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
[TBL] [Abstract][Full Text] [Related]
11. Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases.
Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S240-S247. PubMed ID: 29156912
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study.
Chow E; Loblaw A; Harris K; Doyle M; Goh P; Chiu H; Panzarella T; Tsao M; Barnes EA; Sinclair E; Farhadian M; Danjoux C
Support Care Cancer; 2007 Jun; 15(6):643-647. PubMed ID: 17242910
[TBL] [Abstract][Full Text] [Related]
13. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers.
Hird A; Chow E; Zhang L; Wong R; Wu J; Sinclair E; Danjoux C; Tsao M; Barnes E; Loblaw A
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):193-7. PubMed ID: 19167840
[TBL] [Abstract][Full Text] [Related]
14. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
[TBL] [Abstract][Full Text] [Related]
15. Urinary cytokines/chemokines pattern in patients with painful bone metastases undergoing external beam radiotherapy experiencing pain flare.
Bushehri A; Chow E; Zhang L; Azad A; Vuong S; Pasetka M; Zhou M; Hird A; Dennis K; McDonald R; DeAngelis C
Ann Palliat Med; 2016 Apr; 5(2):107-15. PubMed ID: 27121738
[TBL] [Abstract][Full Text] [Related]
16. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.
Gomez-Iturriaga A; Cacicedo J; Navarro A; Morillo V; Willisch P; Carvajal C; Hortelano E; Lopez-Guerra JL; Illescas A; Casquero F; Del Hoyo O; Ciervide R; Irasarri A; Pijoan JI; Bilbao P
BMC Palliat Care; 2015 Oct; 14():48. PubMed ID: 26427616
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
[TBL] [Abstract][Full Text] [Related]
18. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.
Chow E; Ling A; Davis L; Panzarella T; Danjoux C
Radiother Oncol; 2005 Apr; 75(1):64-9. PubMed ID: 15878102
[TBL] [Abstract][Full Text] [Related]
19. Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial.
Loblaw DA; Wu JS; Kirkbride P; Panzarella T; Smith K; Aslanidis J; Warde P
Support Care Cancer; 2007 Apr; 15(4):451-5. PubMed ID: 17093912
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Rapoport BL; Chasen MR; Gridelli C; Urban L; Modiano MR; Schnadig ID; Poma A; Arora S; Kansra V; Schwartzberg LS; Navari RM
Lancet Oncol; 2015 Sep; 16(9):1079-1089. PubMed ID: 26272769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]